- Home
- / Octapharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Octapharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
€2.5 B
FY, 2021
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 2.2B | 2.4B | 2.5B |
| Cost of goods sold | 1.4B | 1.6B | 1.7B |
| Gross profit | 782.8M | 840.5M | 808.2M |
| Gross profit margin, % | 35.4% | 35.1% | 32.2% |
| General and administrative expense | 63.8M | 79.6M | 65.1M |
| Operating expense total | 358.6M | 389.6M | 349.4M |
| EBIT | 424.2M | 450.9M | 458.8M |
| EBIT margin, % | 19.2% | 18.8% | 18.3% |
| Interest income | 3.7M | 5.5M | |
| Interest expense | 64.7M | ||
| Pre tax profit | 427.9M | 386.2M | 464.3M |
| Income tax expense | 24.5M | 10.5M | 26.0M |
| Net Income | 403.4M | 375.7M | 438.3M |